Product Details

Seretide Evohaler

Fluticasone Propionate; Salmeterol (Salmeterol Xinafoate)
125 mcg; 25 mcg
Inhalation powder

ROA

Inhalation, Oral

Applicant Name

GlaxoSmithKline Consumer Nigeria PLC (GSK)

NRN

04-6850

Status

Active


Composition

Each single actuation of Seretide provides: Fluticasone Propionate 125 mcg, Salmeterol Xinafoate equivalent to Salmeterol 25 mcg  

ATC Code/ATCvet Code

R03AK06  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 120 actuations (in Alu can)  

Product Description

Inhalation Aerosol

Manufacturer Name

Glaxo Wellcome Production

Manufacturer Country

FRANCE  

Approval Date

2023-05-25  

Expiry Date

2028-05-24